BR112023002132A2 - Compostos de heteroarila e heterociclila - Google Patents

Compostos de heteroarila e heterociclila

Info

Publication number
BR112023002132A2
BR112023002132A2 BR112023002132A BR112023002132A BR112023002132A2 BR 112023002132 A2 BR112023002132 A2 BR 112023002132A2 BR 112023002132 A BR112023002132 A BR 112023002132A BR 112023002132 A BR112023002132 A BR 112023002132A BR 112023002132 A2 BR112023002132 A2 BR 112023002132A2
Authority
BR
Brazil
Prior art keywords
heteroaryl
heterocyclyl compounds
compounds
heterocyclyl
formulas
Prior art date
Application number
BR112023002132A
Other languages
English (en)
Portuguese (pt)
Inventor
Heidebrecht Richard
P Hencken Christopher
De Paolis Omar
Wang Weiheng
Buchanan Matthew
Original Assignee
Sigilon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigilon Therapeutics Inc filed Critical Sigilon Therapeutics Inc
Publication of BR112023002132A2 publication Critical patent/BR112023002132A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR112023002132A 2020-08-04 2021-08-04 Compostos de heteroarila e heterociclila BR112023002132A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063060968P 2020-08-04 2020-08-04
PCT/US2021/044564 WO2022031862A2 (en) 2020-08-04 2021-08-04 Heteroaryl and heterocyclyl compounds

Publications (1)

Publication Number Publication Date
BR112023002132A2 true BR112023002132A2 (pt) 2023-04-11

Family

ID=80120142

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023002132A BR112023002132A2 (pt) 2020-08-04 2021-08-04 Compostos de heteroarila e heterociclila

Country Status (9)

Country Link
US (1) US20230303502A1 (cg-RX-API-DMAC7.html)
EP (1) EP4192468A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023536633A (cg-RX-API-DMAC7.html)
KR (1) KR20230048523A (cg-RX-API-DMAC7.html)
CN (1) CN116322777A (cg-RX-API-DMAC7.html)
AU (1) AU2021321433A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023002132A2 (cg-RX-API-DMAC7.html)
CA (1) CA3190778A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022031862A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4531879A1 (en) 2022-05-25 2025-04-09 Flagship Pioneering Innovations VI, LLC Compositions of secretory and/or catalytic cells and methods using the same
JP2025520113A (ja) 2022-06-03 2025-07-01 フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー 組成物及び方法
IL328729A (en) 2023-12-01 2026-07-01 Sigilon Therapeutics Inc Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2411197A (en) * 1996-04-30 1997-11-19 Affymax Technologies N.V. Methods for the synthesis of fmoc protected amines
CN103819403B (zh) * 2008-12-31 2017-01-04 阿德利克斯公司 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法
ES3036749T3 (en) * 2014-08-01 2025-09-23 Massachusetts Inst Technology Modified alginates for anti-fibrotic materials and applications
EP3215519A1 (en) * 2014-11-06 2017-09-13 Novartis AG Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
US20180185368A1 (en) * 2014-11-06 2018-07-05 Lysosomal Therapeutics Inc. Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
CR20180229A (es) * 2015-10-29 2018-08-24 Novartis Ag Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll
KR20230156818A (ko) * 2016-10-03 2023-11-14 시질론 테라퓨틱스, 인크. 화합물, 장치, 및 이의 용도
IL315310A (en) * 2017-12-26 2024-10-01 Kymera Therapeutics Inc Irak degraders and uses thereof
CN112203646A (zh) * 2018-04-04 2021-01-08 西吉隆医疗股份有限公司 可植入颗粒和相关方法

Also Published As

Publication number Publication date
JP2023536633A (ja) 2023-08-28
WO2022031862A2 (en) 2022-02-10
KR20230048523A (ko) 2023-04-11
US20230303502A1 (en) 2023-09-28
EP4192468A4 (en) 2024-09-11
WO2022031862A3 (en) 2022-03-24
CA3190778A1 (en) 2022-02-10
EP4192468A2 (en) 2023-06-14
AU2021321433A1 (en) 2023-03-02
CN116322777A (zh) 2023-06-23

Similar Documents

Publication Publication Date Title
BR112021020285A2 (pt) Métodos e composições para degradação de proteína alvejada
MX2022005839A (es) Compuestos utiles como inhibidores de la proteina helios.
BR112022001067A2 (pt) Inibidores duplos de atm e dna-pk para uso em terapia antitumoral
BR112021025655A2 (pt) Inibidores da replicação do vírus da imunodeficiência humana
BR112017022605A2 (pt) ?composto, composição, e, método para tratamento de infecção por hiv?.
BR112021025528A2 (pt) Derivados de sulfonamida de benzisoxazol
BR112017022544A2 (pt) ?composto, composição, e, método para tratamento de infecção por hiv?.
UY38144A (es) Inhibidores de la señalización mediada por tirosina cinasa
MX386103B (es) Inhibidores de mcl-1 y metodos de uso de los mismos.
MX2020007392A (es) Compuestos de benzamida.
DOP2021000062A (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
MX2022011601A (es) Compuestos de oxoisoindolina sustituidos para el tratamiento del cancer.
BR112022006279A2 (pt) Heteroaril-bifenil aminas para o tratamento de doenças pd-l1
BR112022006018A2 (pt) Heteroaril-bifenil amidas para o tratamento de doenças relacionadas à pd-l1
BR112022006292A2 (pt) Compostos heterobicílicos de arila como bloqueadores de canais de agitador de potássio kv1.3
BR112013006360A2 (pt) derivados de pirazina como bloqueadores de enac
BR112022006507A2 (pt) Compostos heterocíclicos de arilmetileno como bloqueadores de canais de agitador de potássio kv1.3
BR112022008575A2 (pt) Bloqueadores de canal iônico carregado e métodos para uso
CL2023002966A1 (es) Compuestos de oxoisoindolina sustituidos con piridinilo
BR112022022608A2 (pt) Compostos como inibidores de bcl-2
BR112021011325A2 (pt) Derivados de rapamicina
EA202091400A1 (ru) Производные пиррола в качестве ингибиторов асс
EA202192845A1 (ru) Новые композиции, содержащие мелфлуфен
BR112022022367A2 (pt) Derivados e síntese de ácido borônico, formas polimórficas e usos terapêuticos dos mesmos
BR112022014020A2 (pt) Derivado de isoindolina e composição farmacêutica e uso do mesmo